Stoke Therapeutics Inc $ 59.89 1.35 (2.31%)
Volume:
222,034
Avg Vol (1m):
128,408
Market Cap $:
2.19 Bil
Enterprise Value $:
2.00 Bil
PE Ratio:
0.00
PB Ratio:
10.35
Financial Strength | 6/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 171.1 | ||
Debt-to-Equity | 0.01 | ||
Debt-to-EBITDA | -0.02 | ||
Interest Coverage | No Debt | ||
WACC vs ROIC |
Profitability Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -22.39 | ||
ROA % | -21.77 | ||
ROC (Joel Greenblatt) % | -1371.53 |
STOK
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 10.35 | ||
EV-to-EBIT | -40.42 | ||
EV-to-EBITDA | -41.07 | ||
Current Ratio | 29.02 | ||
Quick Ratio | 29.02 |
Dividend & Buy Back |
Current | Vs Industry | Vs History |
---|
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 10.34 | ||
Earnings Yield (Greenblatt) % | -2.47 |